Abstract
Fifty patients who had recently had a transient ischaemic attack took part in a double-blind cross-over trial of sulphinpyrazone 200 mg 4 times daily against placebo. Each treatment was given for 4 months. The incidence of recurrences was much greater in the initial 4 months but there was no difference between the 2 treatments. A follow-up of 39 of the patients showed that 2 years later 90% of those who had not had a recurrence during the 8 months had suffered no further neurological events whereas of those who did have a recurrence during the study only 47% had no further neurological events.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Acheson J., Hutchinson E. C. The natural history of "focal cerebral vascular disease". Q J Med. 1971 Jan;40(157):15–23. [PubMed] [Google Scholar]
- Turpie A. G., Hirsh J. Platelet suppressive therapy. Br Med Bull. 1978 May;34(2):183–190. doi: 10.1093/oxfordjournals.bmb.a071490. [DOI] [PubMed] [Google Scholar]